AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 400 participants.
Also called NCT07684690
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 400 participants
- Registry
-
NCT07684690
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07684690. Randomized; single masking; primary purpose treatment. Start 2026-07 (anticipated); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- AI-Assisted Antidiabetic Drug Consultation System for Glycemic Control in Type 2 Diabetes Patients Managed by Non-Specialist Physicians
- Acronym
- AI-ADCS
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Intervention (Device)
- AI-assisted antidiabetic drug consultation system
- Intervention (Other)
- Manual antidiabetic prescribing (without AI)
- Lead sponsor
- National Taiwan University Hospital
Record details
- Record id
cardio:ct-nct07684690- Content hash
fc52a446f78ada0218b40f291d60c9273bd60fe243f3339f3ab19e4457b237e9